News

Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery

Dr. Joan Fabregat Prous, a principal investigator of the IDIBELL hepato-biliary-pancreatic pathology research group and head of the section of the General and Digestive Surgery Service of the Bellvitge University Hospital, received the “Pere Virgili Award” on October 14th. The event took place at the Royal Academy of Medicine of Catalonia.

Leer más about Dr. Joan Fabregat receives the Virgili Award from the Catalan Society of Surgery

A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D

Music plays a key role in our lives: it has the inherent ability to evoke a wide range of emotions and feelings and it is used as a powerful mood regulator. But strong individual differences have been observed in the intrinsic motivation to look for new music and enjoy it. For example, while some people […]

Leer más about A team of neuroscientist from IDIBELL performed an experiment about musical curiosity at Sónar+D

Adolescents consumed less alcohol, cannabis, and tobacco during lockdown

This is one of the conclusions of a study carried out within the framework of the DESKcohort project, in which 303 people between 14 and 18 years old participated

Leer más about Adolescents consumed less alcohol, cannabis, and tobacco during lockdown

A study identifies risk factors for severe COVID-19 in HIV patients

Results show that people with HIV who suffer from other chronic diseases, have a detectable viral load in their blood, were born outside Spain and/or are over 65 years old, could have a higher risk of suffering from severe COVID-19.

Leer más about A study identifies risk factors for severe COVID-19 in HIV patients

A study estimates the number of people at high risk of developing lung cancer in Spain

The results of this study have been published in the scientific journal Archives of Bronconeumology and it has been lead by members of the Early Cancer Detection group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan nstitute of Oncology (ICO).

Leer más about A study estimates the number of people at high risk of developing lung cancer in Spain

The PhD Day returns this year stronger than ever

Last Friday, October 22, the sixth edition of IDIBELL’s PhD Day took place in the Faculty of Medicine and Health Sciences of the University of Barcelona. In this edition, it has been presented 10 oral communications and 44 scientific posters.

Leer más about The PhD Day returns this year stronger than ever

Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients

One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.

Leer más about Nanopolymer treatment prevents the formation of protein aggregates in neurons derived from Parkinson’s patients

Identified two drugs with antitumor activity in preclinical models of malignant pleural cancer

Researchers from IDIBELL and ICO describe that CDK4 and CDK6 inhibitors stop tumor cell proliferation and expand the life expectancy in animal models.

Leer más about Identified two drugs with antitumor activity in preclinical models of malignant pleural cancer

The Viladecans Against Cancer Association launches the new fundraising campaign

Coinciding with the commemoration of World Breast Cancer Day, the Viladecans Against Cancer Association held the opening ceremony of its new fundraising campaign for research

Leer más about The Viladecans Against Cancer Association launches the new fundraising campaign
Scroll to Top